My SciELO
Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Archivos de la Sociedad Española de Oftalmología
Print version ISSN 0365-6691
Abstract
VLEMING, E.N.; PEREZ-RICO, C.; MONTES, M.A. and PAREJA, J.. Peristent corneal defects treated with botulinum toxin-induced ptosis. Arch Soc Esp Oftalmol [online]. 2007, vol.82, n.9, pp.547-550. ISSN 0365-6691.
Objectives: To evaluate the use of botulinum toxin (BTX) induced ptosis in the treatment of corneal pathology. Methods: We employed two BTX injections into the superior lid of 10 eyes (9 patients). We evaluated the degree of ptosis, its duration and the effect on the corneal lesion. Results: Complete ptosis resulted in seven eyes and the corneal pathology resolved in all of them. There were no relevant complications. Conclusions: BTX treatment is a simple and safe technique for treating refractory corneal pathology. It has significant advantages over surgical tarsorrhaphy and is especially useful where the pathology does not require surgery.
Keywords : Tarsorrhaphy; botulinum toxin; ptosis; persistent corneal defect; contact lens; autologous serum.